(CIRB) DART: Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors

SWOG-S1609
NCT02834013
Cancer - Anus, Cancer - Bladder, Cancer - Brain and Nervous System, Cancer - Breast, Cancer - Cervix, Cancer - Colon, Cancer - Corpus Uteri, Cancer - Esophagus, Cancer - Kidney, Cancer - Lip, Oral Cavity and Pharynx, Cancer - Liver, Cancer - Lung, Cancer - Melanoma, skin, Cancer - Other Digestive Organ, Cancer - Other Endocrine System, Cancer - Other Female Genital, Cancer - Other Male Genital, Cancer - Other Respiratory and Intrathoracic Organs, Cancer - Other Skin, Cancer - Other Urinary, Cancer - Ovary, Cancer - Pancreas, Cancer - Prostate, Cancer - Rectum, Cancer - Small Intestine, Cancer - Soft Tissue, Cancer - Stomach, Cancer - Thyroid, Cancer - Unknown Sites
Daniela Bota
Open
Treatment
BMS-734016, BMS-936558, Ipilimumab, MDX-010 Transfectoma-derived, MDX-1106, Nivolumab
II
Adult
Local

For information about cancer clinical trials at the UCI Health Chao Family Comprehensive Cancer Center, call toll-free 877-UC-STUDY (877-827-8839) or email ucstudy@uci.edu.